End-of-day quote
Taipei Exchange
18:00:00 2024-06-25 EDT
|
5-day change
|
1st Jan Change
|
30
TWD
|
-1.15%
|
|
+0.67%
|
-13.79%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,079
|
1,662
|
2,515
|
1,847
|
1,800
|
1,481
|
Enterprise Value (EV)
1 |
2,264
|
2,182
|
3,006
|
2,413
|
2,537
|
2,270
|
P/E ratio
|
76.7
x
|
24.6
x
|
32.7
x
|
48.2
x
|
-57.9
x
|
-34.8
x
|
Yield
|
-
|
3.18%
|
2.71%
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.23
x
|
1.63
x
|
2.76
x
|
1.92
x
|
1.7
x
|
1.22
x
|
EV / Revenue
|
2.43
x
|
2.14
x
|
3.3
x
|
2.51
x
|
2.4
x
|
1.86
x
|
EV / EBITDA
|
167
x
|
52.7
x
|
35.3
x
|
33.4
x
|
36.5
x
|
34.3
x
|
EV / FCF
|
-117
x
|
40
x
|
36.6
x
|
12
x
|
46.8
x
|
18.6
x
|
FCF Yield
|
-0.85%
|
2.5%
|
2.73%
|
8.3%
|
2.14%
|
5.38%
|
Price to Book
|
4.29
x
|
3.13
x
|
4.41
x
|
3.96
x
|
4.18
x
|
3.62
x
|
Nbr of stocks (in thousands)
|
42,550
|
42,550
|
42,550
|
42,550
|
42,550
|
42,550
|
Reference price
2 |
48.87
|
39.05
|
59.10
|
43.40
|
42.30
|
34.80
|
Announcement Date
|
19-04-01
|
20-03-30
|
21-03-25
|
22-03-30
|
23-03-29
|
24-03-27
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
931
|
1,020
|
910.2
|
959.5
|
1,059
|
1,218
|
EBITDA
1 |
13.55
|
41.44
|
85.15
|
72.18
|
69.54
|
66.19
|
EBIT
1 |
-18.23
|
14.12
|
60.89
|
45.64
|
37.99
|
24.79
|
Operating Margin
|
-1.96%
|
1.38%
|
6.69%
|
4.76%
|
3.59%
|
2.03%
|
Earnings before Tax (EBT)
1 |
30.08
|
69.79
|
107.4
|
56.58
|
-30.18
|
-28.44
|
Net income
1 |
27.11
|
67.62
|
77.16
|
38.54
|
-30.9
|
-42.53
|
Net margin
|
2.91%
|
6.63%
|
8.48%
|
4.02%
|
-2.92%
|
-3.49%
|
EPS
2 |
0.6372
|
1.588
|
1.810
|
0.9000
|
-0.7300
|
-1.000
|
Free Cash Flow
1 |
-19.31
|
54.56
|
82.03
|
200.3
|
54.23
|
122
|
FCF margin
|
-2.07%
|
5.35%
|
9.01%
|
20.88%
|
5.12%
|
10.02%
|
FCF Conversion (EBITDA)
|
-
|
131.67%
|
96.34%
|
277.56%
|
77.99%
|
184.37%
|
FCF Conversion (Net income)
|
-
|
80.69%
|
106.31%
|
519.79%
|
-
|
-
|
Dividend per Share
|
-
|
1.243
|
1.600
|
-
|
-
|
-
|
Announcement Date
|
19-04-01
|
20-03-30
|
21-03-25
|
22-03-30
|
23-03-29
|
24-03-27
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
185
|
520
|
492
|
566
|
737
|
790
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
13.65
x
|
12.55
x
|
5.775
x
|
7.84
x
|
10.6
x
|
11.93
x
|
Free Cash Flow
1 |
-19.3
|
54.6
|
82
|
200
|
54.2
|
122
|
ROE (net income / shareholders' equity)
|
4.46%
|
11.1%
|
15.7%
|
7%
|
-6.98%
|
-8.28%
|
ROA (Net income/ Total Assets)
|
-1.04%
|
0.7%
|
2.71%
|
2.06%
|
1.64%
|
0.99%
|
Assets
1 |
-2,613
|
9,600
|
2,847
|
1,868
|
-1,885
|
-4,285
|
Book Value Per Share
2 |
11.40
|
12.50
|
13.40
|
11.00
|
10.10
|
9.600
|
Cash Flow per Share
2 |
2.680
|
1.710
|
2.360
|
2.000
|
2.160
|
2.160
|
Capex
1 |
18.1
|
11.1
|
10.5
|
40.3
|
142
|
36.6
|
Capex / Sales
|
1.94%
|
1.09%
|
1.16%
|
4.2%
|
13.4%
|
3.01%
|
Announcement Date
|
19-04-01
|
20-03-30
|
21-03-25
|
22-03-30
|
23-03-29
|
24-03-27
|
|
1st Jan change
|
Capi.
|
---|
| -13.79% | 39.15M | | +25.79% | 89.18B | | -23.21% | 76.11B | | +1.62% | 27.11B | | -10.58% | 17.13B | | -0.21% | 16.83B | | +0.52% | 15.4B | | +77.83% | 13.68B | | +79.56% | 13.25B | | -25.79% | 12.83B |
Other Healthcare Facilities & Services
|